Short- and long-term outcomes of adrenalectomy for primary aldosteronism in a single UK center: rear-mirror view
Hormones · 2025-03 · 24 (1) · 251-258
DOI: 10.1007/s42000-024-00613-3 ↗Kurz gefasst
Fachartikel in der Zeitschrift Hormones, online erschienen am 18.11.2024. Verfasst von Tarek Abdel-Aziz und 7 weiteren Autor:innen. Beteiligte Einrichtung: Centre for Endocrine Surgery, University College London Hospitals NHS Foundation Trust, 250 Euston Road, London, NW1 2PG, UK. t.abdel-aziz@ucl.ac.uk. Hauptthemen laut MEDLINE: Adrenalectomy, Hyperaldosteronism. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 28 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Purpose
Primary aldosteronism (PA), which is the commonest cause of secondary hypertension, can be cured by unilateral adrenalectomy. We report the short-and long-term outcomes after adrenalectomy performed at a single UK center over a period of 24 years.
Methods
Retrospective analysis of biochemical (potassium, aldosterone, renin, and ARR) radiological (CT/MRI, AVS, and nuclear scans), and clinical (surgical complications, blood pressure, and number of antihypertensive medications) short-and long-terms outcomes in patients who underwent adrenalectomy for PA between 1998 and 2021. Standardized PASO and Clavien-Dindo criteria to assess biochemical, clinical, and surgical outcomes were used.
Results
A total of 82 patients were treated via adrenalectomy for PA over a 24-year period. Short-term follow-up data (within 3 months after surgery) was available for all 82 patients (M45, F37, mean age 51.7 years): 24 of them were followed up for at least 60 months (range 60 to 72 months) and 77 (93.9%) patients had laparoscopic surgery (one conversion). Seven patients had postoperative complications classified as Clavien-Dindo II (4), IIIa(1) and IVa(2). Median LOS was 2.5 days (1–12). Complete and partial clinical success was achieved in 29 and 58.3% and 41.7 and 45.8% of patients in the short and the long term, respectively. Clinical benefit was observed in 88% of patients. Complete biochemical success was achieved in 95.8% of patients in the short and the long term.
Conclusion
Unilateral adrenalectomy in patients with PA showed clinical benefit in 88% and achieved biochemical cure in almost all of them. Our data suggest that these benefits persisted for at least 5 years.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Centre for Endocrine Surgery, University College London Hospitals NHS Foundation Trust, 250 Euston Road, London, NW1 2PG, UK. t.abdel-aziz@ucl.ac.uk.
- Centre for Endocrine Surgery, University College London Hospitals NHS Foundation Trust, 250 Euston Road, London, NW1 2PG, UK.
- Faculty of Medicine, Alexandria University, Alexandria, Egypt.
- Endocrinology department, University College London Hospitals NHS Foundation Trust, London, UK.
Zitieren
APA
Abdel-Aziz, T., Abdelsalam, A., Chung, T. T., Srirangalingam, U., Hurel, S., Conway, G., Baldeweg, S. E., & Kurzawinski, T. R. (2025). Short- and long-term outcomes of adrenalectomy for primary aldosteronism in a single UK center: rear-mirror view. Hormones, 24(1), 251-258. https://doi.org/10.1007/s42000-024-00613-3
Vancouver
Abdel-Aziz T, Abdelsalam A, Chung TT, Srirangalingam U, Hurel S, Conway G, et al. Short- and long-term outcomes of adrenalectomy for primary aldosteronism in a single UK center: rear-mirror view. Hormones. 2025;24(1):251-258. doi:10.1007/s42000-024-00613-3
BibTeX
@article{AbdelAziz2025,
author = {Abdel-Aziz, Tarek and Abdelsalam, Alaa and Chung, Teng-Teng and Srirangalingam, Umasuthan and Hurel, Steven and Conway, Gerard and Baldeweg, Stephanie E and Kurzawinski, Tom R},
title = {Short- and long-term outcomes of adrenalectomy for primary aldosteronism in a single UK center: rear-mirror view},
journal = {Hormones},
year = {2025},
volume = {24},
number = {1},
pages = {251--258},
doi = {10.1007/s42000-024-00613-3}
}
EUVIMED